de Luis D A, Gonzalez Sagrado M, Conde R, Aller R, Izaola O
Institute of Endocrinology and Nutrition, Medicine School and Unit of Investigation, Hospital Rio Hortega, University of Valladolid, Valladolid, Spain.
Ann Nutr Metab. 2007;51(2):134-8. doi: 10.1159/000103273. Epub 2007 May 29.
Basal glucagon-like peptide-1 (GLP-1) concentrations seem to be attenuated in obese subjects, although statistical significance is unclear. Only a few studies have investigated the effect of weight reduction on GLP-1 concentrations and have found unclear results. The aim of the present study was to determine whether subjects who lose weight on a hypocaloric diet experience the same change in circulating GLP-1 levels as subjects who do not lose weight.
A population of 99 obese nondiabetic outpatients was analyzed in a prospective way. Weight and blood pressure were determined. Basal glucose, C-reactive protein, insulin, total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, and basal GLP-1 blood levels were measured before and after 3 months of hypocaloric diet. Bipolar impedance examination was performed in all patients to assess body composition. The lifestyle modification program consisted of a hypocaloric diet (1,520 kcal, 52% carbohydrates, 25% lipids and 23% proteins). The exercise program consisted of aerobic exercise for at least 3 times per week (60 min each).
Ninety-nine patients (20 male/79 female) gave informed consent and were enrolled in the study. Fourteen patients (2 male/12 female) did not lose weight (group I: weight increase of 2 +/- 1.1 kg, NS) and 75 patients (18 male/67 female) lost weight (group II, weight loss of 4 +/- 1.6 kg, p < 0.05). Weight, body mass index, fat mass, waist circumference, insulin, HOMA, LDL cholesterol, triglycerides and systolic blood pressure improved in group II, without significant statistical changes in group I. In group I, basal GLP-1 levels remained unchanged (7.4 +/- 3.1 vs. 7.15 +/- 3.6 ng/ml, NS). In group II, GLP-1 levels decreased significantly (8.4%, 6.88 +/- 2.5 vs. 6.3 +/- 2.4 ng/ml, p < 0.05). In the multivariate analysis with a dependent variable (levels of GLP-1 after hypocaloric diet adjusted by age and sex), only insulin levels remained as an independent predictor in the model (F = 5.9; p < 0.05), with an increase of 0.6 ng/ml (CI 95%: 0.1-1.1) in GLP-1 concentrations with each 1-mIU/ml increase of insulin.
Hypocaloric diet decreased GLP-1 levels in patients with weight loss with a significant improvement in anthropometric parameters and cardiovascular risk factors. Nevertheless, patients without weight loss after dietary treatment exhibited unchanged GLP-1 levels. Basal insulin correlates with basal GLP-1.
基础胰高血糖素样肽-1(GLP-1)浓度在肥胖受试者中似乎有所降低,尽管统计学意义尚不清楚。仅有少数研究调查了体重减轻对GLP-1浓度的影响,结果并不明确。本研究的目的是确定低热量饮食减肥的受试者与未减肥的受试者循环GLP-1水平的变化是否相同。
前瞻性分析了99例肥胖非糖尿病门诊患者。测定体重和血压。在低热量饮食3个月前后测量基础血糖、C反应蛋白、胰岛素、总胆固醇、低密度脂蛋白胆固醇、高密度脂蛋白胆固醇、甘油三酯以及基础GLP-1血水平。对所有患者进行双极阻抗检查以评估身体成分。生活方式改变计划包括低热量饮食(1520千卡,52%碳水化合物,25%脂质和23%蛋白质)。运动计划包括每周至少进行3次有氧运动(每次60分钟)。
99例患者(20例男性/79例女性)签署知情同意书并纳入研究。14例患者(2例男性/12例女性)未减肥(第一组:体重增加2±1.1千克,无统计学意义),75例患者(18例男性/67例女性)减肥(第二组,体重减轻4±1.6千克,p<0.05)。第二组的体重、体重指数、脂肪量、腰围、胰岛素、稳态模型评估胰岛素抵抗(HOMA)、低密度脂蛋白胆固醇、甘油三酯和收缩压有所改善,第一组无显著统计学变化。在第一组中,基础GLP-1水平保持不变(7.4±3.1对7.15±3.6纳克/毫升,无统计学意义)。在第二组中,GLP-1水平显著降低(8.4%,6.88±2.5对6.3±2.4纳克/毫升,p<0.05)。在以因变量(按年龄和性别调整后的低热量饮食后GLP-1水平)进行的多变量分析中,模型中仅胰岛素水平作为独立预测因子保留(F=5.9;p<0.05),胰岛素每增加1毫国际单位/毫升,GLP-1浓度增加0.6纳克/毫升(95%置信区间:0.1-1.1)。
低热量饮食使减肥患者的GLP-1水平降低,人体测量参数和心血管危险因素有显著改善。然而,饮食治疗后未减肥的患者GLP-1水平未改变。基础胰岛素与基础GLP-1相关。